Inhibiting genes controlling cell lipogenesis, such as SCD1, has been reported to overcome therapeutic resistance in various cancers.34,35 Interestingly, in this study, we found that oxaliplatin rather than 5-Fu sensitised SCD1-KD cells to chemotherapy. Here, SCD is linked to cancer.